NIAGADS:阿尔茨海默病和相关痴呆症基因组学数据库
Amanda Kuzma1, Otto Valladares1, Emily Greenfest-Allen1
1Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
概括
国家阿尔茨海默病遗传老龄化研究所数据存储网站 (NIAGADS) 为阿尔茨海默病研究提供了关键的遗传数据. 它通过其广泛的数据库和开放式访问知识库,促进全球协作和发现.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 神经科学是一个神经科学.
- 数据科学数据科学数据科学
背景情况:
- 国家阿尔茨海默病衰老遗传研究所数据存储站点 (NIAGADS) 是阿尔茨海默病和相关痴呆症 (ADRD) 人类遗传学研究的指定国家存储库.
- 它拥有高质量的遗传和基因组数据集合,包括整个基因组和外基因组序列,以及来自超过211,000个样本的基因型/表型数据.
研究的目的:
- 作为ADRD遗传学研究的中央数据库.
- 支持遗传学数据的生产,分析和共享.
- 促进合作,促进对阿尔茨海默病的理解和治疗.
主要方法:
- 数据整理和存储遗传/基因组数据,包括来自阿尔茨海默氏病测序项目的全基因组测序.
- 开发和维护一个适度合规的联邦信息安全现代化法案 (FISMA) 基于云的数据共享平台.
- 创建具有全基因组关联总结统计和变异/基因注释的开放获取知识库.
主要成果:
- NIAGADS管理着一个包括211,000个样本在内的全面数据集,用于ADRD和健康衰老遗传学研究.
- 阿尔茨海默病测序项目数据集代表了ADRD最大的联合称为全基因组测序数据集 (约有58,000个基因组).
- 数据通过安全的数据共享服务与全球数百个研究小组共享,遵守NIH基因组数据共享政策.
结论:
- NIAGADS是阿尔茨海默病遗传学的关键资源,使开放和合格的数据访问成为可能.
- 该存储库通过提供有价值的数据集和用于探索遗传关联的工具来促进研究.
- 它的作用对于推动合作努力,以了解和打击阿尔茨海默病和相关痴呆症至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:30Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182
01:11Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K